Description
The youth will join the firm's’ oligonucleotide synthesis team to support the development, evaluation, production, and delivery of chemically-modified aptamer sequences and other oligonucleotide therapeutic candidates for the firm's clients…
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02024-10-28$30,000
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2024-10-28(start date) | $30,000 | — | The youth will join the firm's’ oligonucleotide synthesis team to support the development, evaluation, product… |
Related records · 11
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 742964521)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 172-2025-2026-Q4-1039317 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program | $357,087 | FY2026 |
| 172-2024-2025-Q4-1025518 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $71,500 | FY2025 |
| 172-2024-2025-Q3-1022902 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $63,000 | FY2025 |
| 172-2023-2024-Q2-1008172 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $527,000 | FY2024 |
| 271-2021-2022-Q4-00124 | Health Canada | Santé Canada · Canadian Health Systems and Programs | $940,000 | FY2022 |
| 172-2020-2021-Q2-955723 | National Research Council Canada | Conseil national de recherches Canada · Innovative Solutions Canada | $266,500 | FY2021 |
Other recipients funded under "Industrial Research Assistance Program – Youth Employment Program" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2026-2027-Q1-1043891 | Ripple Therapeutics Corporation | FY2027 | $25,000 | FY2027 |
| 172-2026-2027-Q1-1044015 | BackSCNR Inc. | FY2027 | $30,000 | FY2027 |
| 172-2026-2027-Q1-1043828 | Marwood Ltd. | FY2027 | $30,000 | FY2027 |
| 172-2026-2027-Q1-1043785 | PURITY-IQ INCORPORATED | FY2027 | $30,000 | FY2027 |
| 172-2026-2027-Q1-1044062 | Smart City Water Inc. | FY2027 | $30,000 | FY2027 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2024-2025-Q3-1023902 · retrieved 2026-11-13.